Literature DB >> 8083996

An assembly domain of the Rous sarcoma virus Gag protein required late in budding.

J W Wills1, C E Cameron, C B Wilson, Y Xiang, R P Bennett, J Leis.   

Abstract

The Gag protein of Rous sarcoma virus has the ability to direct particle assembly at the plasma membrane in the absence of all the other virus-encoded components. An extensive deletion analysis has revealed that very large regions of this protein can be deleted without impairing budding and has suggested that the essential functions map to three discrete regions. In the studies reported here, we establish the location of assembly domain 2 (AD2) within the proline-rich p2b sequence of this Gag protein. AD2 mutants lacking the p2b sequence were completely defective for particle release even though their Gag proteins were tightly associated with the membrane fraction and exhibited high levels of protease activity. Mutations that inactivate the viral protease did not restore budding to wild-type levels for these mutants, indicating that the defect is not due simply to a loss of protease regulation. AD2 mutants could be rescued into dense particles in genetic complementation assays, indicating that their defect is not due to a gross alteration of the overall conformation of the protein and that the assembly function is not needed on every Gag molecule in the population. Several mutants with amino acid substitutions in the p2b sequence were found to have an intermediate capacity for budding. Inactivation of the protease of these mutants stabilized the Gag polyprotein within the cells and allowed an increase in particle release; however, the rate of budding remained slow. We favor the idea that AD2 is a dynamic region of movement, perhaps serving as a molecular hinge to allow the particle to emerge from the surface of the cell during budding.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8083996      PMCID: PMC237081     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  Processing of avian retroviral gag polyprotein precursors is blocked by a mutation at the NC-PR cleavage site.

Authors:  H Burstein; D Bizub; M Kotler; G Schatz; V M Vogt; A M Skalka
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

2.  Structure of B77 sarcoma virus RNA: stabilization of RNA after packaging.

Authors:  C M Stoltzfus; P N Snyder
Journal:  J Virol       Date:  1975-11       Impact factor: 5.103

3.  Role of the avian retroviral protease in the activation of reverse transcriptase during virion assembly.

Authors:  R C Craven; R P Bennett; J W Wills
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

4.  Assembly and processing of avian retroviral gag polyproteins containing linked protease dimers.

Authors:  H Burstein; D Bizub; A M Skalka
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

5.  Specific inhibitor of human immunodeficiency virus proteinase prevents the cytotoxic effects of a single-chain proteinase dimer and restores particle formation.

Authors:  H G Kräusslich
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

6.  Analysis of HIV particle formation using transient expression of subviral constructs in mammalian cells.

Authors:  K Mergener; M Fäcke; R Welker; V Brinkmann; H R Gelderblom; H G Kräusslich
Journal:  Virology       Date:  1992-01       Impact factor: 3.616

7.  Comparison of immature (rapid harvest) and mature Rous sarcoma virus particles.

Authors:  K S Cheung; R E Smith; M P Stone; W K Joklik
Journal:  Virology       Date:  1972-12       Impact factor: 3.616

8.  Nucleotide sequence of Rous sarcoma virus.

Authors:  D E Schwartz; R Tizard; W Gilbert
Journal:  Cell       Date:  1983-03       Impact factor: 41.582

9.  Rauscher leukemia virus populations enriched for "immature" virions contain increased amounts of P70, the gag gene product.

Authors:  R B Luftig; Y Yoshinaka
Journal:  J Virol       Date:  1978-01       Impact factor: 5.103

10.  Polyproteins related to the major core protein of mouse mammary tumor virus.

Authors:  C Dickson; M Atterwill
Journal:  J Virol       Date:  1978-06       Impact factor: 5.103

View more
  176 in total

Review 1.  Ubiquitin in retrovirus assembly: actor or bystander?

Authors:  V M Vogt
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

2.  Ubiquitin is part of the retrovirus budding machinery.

Authors:  A Patnaik; V Chau; J W Wills
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

3.  Insertion of capsid proteins from nonenveloped viruses into the retroviral budding pathway.

Authors:  N K Krishna; J W Wills
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

4.  In vivo interference of Rous sarcoma virus budding by cis expression of a WW domain.

Authors:  Akash Patnaik; John W Wills
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

5.  Nuclear entry and CRM1-dependent nuclear export of the Rous sarcoma virus Gag polyprotein.

Authors:  Lisa Z Scheifele; Rachel A Garbitt; Jonathan D Rhoads; Leslie J Parent
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

6.  Identification of the lymphocytic choriomeningitis virus (LCMV) proteins required to rescue LCMV RNA analogs into LCMV-like particles.

Authors:  Ki Jeong Lee; Mar Perez; Daniel D Pinschewer; Juan Carlos de la Torre
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

Review 7.  Viral late domains.

Authors:  Eric O Freed
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

8.  Membrane targeting properties of a herpesvirus tegument protein-retrovirus Gag chimera.

Authors:  J B Bowzard; R J Visalli; C B Wilson; J S Loomis; E M Callahan; R J Courtney; J W Wills
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

9.  Role of ESCRT-I in retroviral budding.

Authors:  Juan Martin-Serrano; Trinity Zang; Paul D Bieniasz
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

10.  Regulation of host cell transcriptional physiology by the avian pneumovirus provides key insights into host-pathogen interactions.

Authors:  Shirin Munir; Vivek Kapur
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.